More and more patients come to Finland to seek better treatment—including cancer treatment. Patients’ freedom to choose the place of treatment has grown; for example, in line with the EU directive. We have noticed this at Docrates—we have treated patients from over 40 countries and the number of foreign patients already makes up one-fifth of our revenue. We are the leader in Finnish health tourism because we are Finland’s largest exporter of healthcare services.
Finnish cancer research is the world’s most cited
Cancer research has traditionally been of very high quality in Finland. In clinical publications in the field of cancer research, for example, Finland is the world leader when examining the average of citations per clinical cancer article (26.4 citations per article):
Finnish cancer treatment is among the best in Europe
A clear statement of the premium quality of Finnish cancer treatment is presented by the EUROCARE Study, which is the most comprehensive source of European statistics on cancer patient survival. The statistics have been collected on a regular basis since 1989, and they provide accurate statistical information on survival rates for different types of cancer in different European countries. The latest published statistics, EUROCARE 5 ( 2000–2007) includes information on more than 21 million cancer cases, covering 30 European countries.
The cancer-specific statistics on cancer patient survival below show that Finland is the best country when it comes to treating head and neck cancers as well as breast cancer, the third best in treating prostate cancer, and the fourth best in treating colorectal cancers.